Matches in SemOpenAlex for { <https://semopenalex.org/work/W3196304790> ?p ?o ?g. }
- W3196304790 endingPage "30" @default.
- W3196304790 startingPage "19" @default.
- W3196304790 abstract "During the development of drug resistance, multiple myeloma (MM) cells undergo changes to their metabolism. However, how these metabolic changes can be exploited to improve treatment efficacy is not known. Here we demonstrate that targeting coenzyme Q10 (CoQ) biosynthesis through the mevalonate pathway works in synergy with the proteasome inhibitor bortezomib (BTZ) in MM. We show that gene expression signatures relating to the mitochondrial tricarboxylic acid (TCA) cycle and electron transport chain (ETC) predispose to clinical BTZ resistance and poor prognosis in MM patients. Mechanistically, BTZ-resistant cells show increased activity of glutamine-driven TCA cycle and oxidative phosphorylation, together with an increased vulnerability towards ETC inhibition. Moreover, BTZ resistance is accompanied by high levels of the mitochondrial electron carrier CoQ, while the mevalonate pathway inhibitor simvastatin increases cell death and decreases CoQ levels, specifically in BTZ-resistant cells. Both in vitro and in vivo, simvastatin enhances the effect of bortezomib treatment. Our study links CoQ synthesis to drug resistance in MM and provides a novel avenue for improving BTZ responses through statin-induced inhibition of mitochondrial metabolism." @default.
- W3196304790 created "2021-09-13" @default.
- W3196304790 creator A5003658156 @default.
- W3196304790 creator A5013496603 @default.
- W3196304790 creator A5020917234 @default.
- W3196304790 creator A5044098004 @default.
- W3196304790 creator A5063892896 @default.
- W3196304790 creator A5072495435 @default.
- W3196304790 creator A5072920562 @default.
- W3196304790 creator A5082410538 @default.
- W3196304790 creator A5085403155 @default.
- W3196304790 creator A5023761173 @default.
- W3196304790 date "2022-01-01" @default.
- W3196304790 modified "2023-09-30" @default.
- W3196304790 title "Targeting coenzyme Q10 synthesis overcomes bortezomib resistance in multiple myeloma" @default.
- W3196304790 cites W1583113866 @default.
- W3196304790 cites W1970960935 @default.
- W3196304790 cites W1972903220 @default.
- W3196304790 cites W1973094248 @default.
- W3196304790 cites W1975203568 @default.
- W3196304790 cites W1979127421 @default.
- W3196304790 cites W1995794901 @default.
- W3196304790 cites W1996365670 @default.
- W3196304790 cites W1999115477 @default.
- W3196304790 cites W2037182429 @default.
- W3196304790 cites W2039180923 @default.
- W3196304790 cites W2060880575 @default.
- W3196304790 cites W2061110648 @default.
- W3196304790 cites W2066363570 @default.
- W3196304790 cites W2090406819 @default.
- W3196304790 cites W2100239923 @default.
- W3196304790 cites W2100510340 @default.
- W3196304790 cites W2117692326 @default.
- W3196304790 cites W2136620344 @default.
- W3196304790 cites W2137386173 @default.
- W3196304790 cites W2143036691 @default.
- W3196304790 cites W2147758888 @default.
- W3196304790 cites W2161160225 @default.
- W3196304790 cites W2166761147 @default.
- W3196304790 cites W2170661703 @default.
- W3196304790 cites W2171504422 @default.
- W3196304790 cites W2195147549 @default.
- W3196304790 cites W2300552860 @default.
- W3196304790 cites W2337073704 @default.
- W3196304790 cites W2343425851 @default.
- W3196304790 cites W2345381093 @default.
- W3196304790 cites W2398639705 @default.
- W3196304790 cites W2412307969 @default.
- W3196304790 cites W2513280988 @default.
- W3196304790 cites W2516988407 @default.
- W3196304790 cites W2522190852 @default.
- W3196304790 cites W2597387377 @default.
- W3196304790 cites W2611224317 @default.
- W3196304790 cites W2751037830 @default.
- W3196304790 cites W2770970846 @default.
- W3196304790 cites W2783093786 @default.
- W3196304790 cites W2797422331 @default.
- W3196304790 cites W2899130161 @default.
- W3196304790 cites W2926343247 @default.
- W3196304790 cites W2933362964 @default.
- W3196304790 cites W2945294912 @default.
- W3196304790 cites W2976327330 @default.
- W3196304790 cites W2982375618 @default.
- W3196304790 cites W3042695800 @default.
- W3196304790 cites W3045113995 @default.
- W3196304790 cites W4211058750 @default.
- W3196304790 doi "https://doi.org/10.1039/d1mo00106j" @default.
- W3196304790 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34879122" @default.
- W3196304790 hasPublicationYear "2022" @default.
- W3196304790 type Work @default.
- W3196304790 sameAs 3196304790 @default.
- W3196304790 citedByCount "7" @default.
- W3196304790 countsByYear W31963047902022 @default.
- W3196304790 countsByYear W31963047902023 @default.
- W3196304790 crossrefType "journal-article" @default.
- W3196304790 hasAuthorship W3196304790A5003658156 @default.
- W3196304790 hasAuthorship W3196304790A5013496603 @default.
- W3196304790 hasAuthorship W3196304790A5020917234 @default.
- W3196304790 hasAuthorship W3196304790A5023761173 @default.
- W3196304790 hasAuthorship W3196304790A5044098004 @default.
- W3196304790 hasAuthorship W3196304790A5063892896 @default.
- W3196304790 hasAuthorship W3196304790A5072495435 @default.
- W3196304790 hasAuthorship W3196304790A5072920562 @default.
- W3196304790 hasAuthorship W3196304790A5082410538 @default.
- W3196304790 hasAuthorship W3196304790A5085403155 @default.
- W3196304790 hasBestOaLocation W31963047901 @default.
- W3196304790 hasConcept C165135838 @default.
- W3196304790 hasConcept C185592680 @default.
- W3196304790 hasConcept C203014093 @default.
- W3196304790 hasConcept C2776329913 @default.
- W3196304790 hasConcept C2776364478 @default.
- W3196304790 hasConcept C2777478702 @default.
- W3196304790 hasConcept C2779384338 @default.
- W3196304790 hasConcept C502942594 @default.
- W3196304790 hasConcept C55493867 @default.
- W3196304790 hasConcept C57600042 @default.
- W3196304790 hasConcept C62231903 @default.
- W3196304790 hasConcept C86803240 @default.